• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Biotechnology in Italy

  • ID: 1923314
  • February 2015
  • Region: Italy
  • 27 pages
  • MarketLine

Introduction

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

- The Italian biotechnology industry had total revenues of $9.2bn in 2014, representing a compound annual growth rate (CAGR) of 5.1% between 2010 and 2014.

- The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $3.8bn, equivalent to 41.7% of the industry's overall value.

- The performance of the industry is forecast to decelerate, with an anticipated CAGR of 4.5% for the five-year period 2014 - 2019, which READ MORE >

Note: Product cover images may vary from those shown

Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Gentium S.p.A.
Menarini Group
Zambon Company S.p.A.
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related research
Appendix
About

LIST OF TABLES
Table 1: Italy biotechnology industry value: $ billion, 2010–14(e)
Table 2: Italy biotechnology industry category segmentation: $ billion, 2014(e)
Table 3: Italy biotechnology industry geography segmentation: $ billion, 2014(e)
Table 4: Italy biotechnology industry value forecast: $ billion, 2014–19
Table 5: Gentium S.p.A.: key facts
Table 6: Menarini Group: key facts
Table 7: Zambon Company S.p.A.: key facts
Table 8: Italy size of population (million), 2010–14
Table 9: Italy gdp (constant 2005 prices, $ billion), 2010–14
Table 10: Italy gdp (current prices, $ billion), 2010–14
Table 11: Italy inflation, 2010–14
Table 12: Italy consumer price index (absolute), 2010–14
Table 13: Italy exchange rate, 2010–14

LIST OF FIGURES
Figure 1: Italy biotechnology industry value: $ billion, 2010–14(e)
Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2014(e)
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2014(e)
Figure 4: Italy biotechnology industry value forecast: $ billion, 2014–19
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2014
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2014
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2014
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2014
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2014
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2014

Note: Product cover images may vary from those shown

Gentium S.p.A., The Menarini Group and Zambon Company S.p.A.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Amgen Inc. Bayer AG Bio-Rad Laboratories, Inc. Beckman Coulter, Inc. Novartis AG Baxter International Inc.